SCHEMBL11434135

SCHEMBL11434135

C=Cc1nnsc1-c1nc([N+](=O)[O-])c[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28920099 0.72 ALDH1A1 (0.33) —
SCHEMBL1602461 0.67 ALDH1A1 (0.34) —
SCHEMBL990710 0.65 MAPT (0.48) —
SCHEMBL11839035 0.64 KMT2A (0.30) —
SCHEMBL11843651 0.62 MAPT (0.36) —
SCHEMBL8016907 0.62 — —
SCHEMBL59059 0.62 — —
SCHEMBL7555586 0.62 — —
SCHEMBL64072 0.61 CYP3A4 (0.33) —
SCHEMBL28819045 0.60 CYP3A4 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4218460-A NITROIMIDAZOLYLVINYLTHIADIAZOLES; TREATMENT OF TRICHOMONIASIS, TRYPANOSOMIASIS, AMOEBIC DYSENTERY BASF AKTIENGESELLSCHAFT (DE) 1980-08-19 — — US claimed
US-4218460-A NITROIMIDAZOLYLVINYLTHIADIAZOLES; TREATMENT OF TRICHOMONIASIS, TRYPANOSOMIASIS, AMOEBIC DYSENTERY BASF AKTIENGESELLSCHAFT (DE) 1980-08-19 — — US disclosed
US-4218460-A NITROIMIDAZOLYLVINYLTHIADIAZOLES; TREATMENT OF TRICHOMONIASIS, TRYPANOSOMIASIS, AMOEBIC DYSENTERY BASF AKTIENGESELLSCHAFT (DE) 1980-08-19 — — US disclosed
Send feedback